Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 30 Jun 2017 for Aptose Biosciences Inc.. Read the official filing
Filing timeline
BuySaleWilliam Glenn Rice
Insider track record
Disclosed buys
1
Disclosed sells
1
Signal history
No signal scores available.
William Glenn Rice: trading record in brief
William Glenn Rice appears in our data through filings on Aptose Biosciences Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 26 June 2017 and the latest from 28 June 2017.
On the open market, the record shows 1 purchase worth €15k and 1 sale worth €15k. Purchases outweigh sales by €27. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 30 June 2017: an option exercise, in Aptose Biosciences Inc. The last purchase on record was published on 30 June 2017, which is 3,400 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William Glenn Rice
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
50,000 sharesCommon SharesTSXSEDI:3028393
18,986 shares@ CA$1.20Common SharesTSXSEDI:3028402
20,000 shares@ CA$1.14Common SharesTSXSEDI:3028391
Canonical exit: 24 Sept 2017 (T+90)
3 of 3 declarations
